Showing results (31-40 of 525) with videos related to
Sort By:
Pageof 53
Acta Medica Austriaca|January 1, 1982
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]H Sinzinger, K Silberbauer, P Fitscha, et al.Experientia|June 15, 1979
Relation between fibrinolytic activity and prostacyclin generation of atherosclerotic artery and dacron prosthetic graftH Sinzinger, K Silberbauer, M Winter, et al.Experimentelle Pathologie|January 1, 1979
Is human arterial smooth muscle cell proliferation regulated by prostacyclin?H Sinzinger, K Silberbauer, M Winter, et al.Zeitschrift Fur Kardiologie|August 1, 1982
[Molsidomine, a coronary drug with platelet-aggregating inhibitory activity]K Silberbauer, J Slany, H Sinzinger, et al.Atherosclerosis|August 1, 1981
Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiographyK Silberbauer, G Schernthaner, H Sinzinger, et al.Lymphology|March 1, 1980
Prostacyclin synthesis in human lymphaticsE Mannheimer, H Sinzinger, R Oppolzer, et al.Wiener Klinische Wochenschrift|February 1, 1980
[Influence of cimetidine, pentagastrin and somatostatin on prostacyclin synthesis of gastric mucosa in vitro]M Winter, H Sinzinger, K Silberbauer, et al.Prostaglandins and Medicine|July 1, 1981
Increased plasma levels of 6-oxo-prostaglandin F1 alpha, a stable metabolite of prostacyclin, in acute kidney transplant rejectionC Leithner, H Sinzinger, B A PeskarProstaglandins|January 1, 1981
Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?H Sinzinger, K Silberbauer, A K Horsch, et al.Lancet (London, England)|February 18, 1984
Parathyroid hormone does not inhibit platelet aggregationC Leithner, J Kovarik, H Sinzinger, et al.Pageof 53